AcuityMD, a provider of a data-driven sales enablement platform designed specifically for the medical technology (MedTech) industry, raised $80 million in a new Series C funding round to advance its platform with cutting-edge artificial intelligence (AI) capabilities and drive the adoption of its medical technology platform.
The investment round was led by existing investor StepStone Group, with additional participation from Benchmark, Redpoint Ventures, ICONIQ, and Atreides Management.
With the Series C round, AcuityMD has raised more than $160 million in equity funding to date, at a $955 million valuation.
AcuityMD was founded in 2019 to solve the root cause of the problem: the commercial insights MedTech companies need are scattered across claims databases, FDA filings, government records, and market signals that no single MedTech company can assemble alone.
AcuityMD aggregates all of it into a proprietary MedTech ontology: a continuously enriched knowledge graph mapping entities including physicians, facilities, networks, procedures, reimbursement dynamics, and the relationships between them. It aligns that ontology with each customer’s internal data, including contracting information, product indications, territory structure, and CRM activity. The result is a unified, always updated view of the healthcare market for faster, smarter commercial execution.
“AI will transform MedTech, but only with the right context, deeply embedded in the workflows where decisions are made. AcuityMD is that context layer, serving the rep in the field, the commercial leader planning territories, and the teams launching the next generation of innovation. I’m grateful to the hundreds of customers who have helped shape our platform,” concluded Mike Monovoukas, CEO and co-founder of AcuityMD.
“This funding accelerates our shared mission of accelerating adoption of cutting-edge medical technologies,” added Mike Monovoukas.
Digital health companies, including medtech software startups, have secured more than $180 billion in funding to date, according to our recent Funding Database.
More recently, Luminai, a provider of an AI-powered healthcare workflow automation platform, raised $38 million in a Series B funding round, bringing its total funding to date to $60 million.
In another deal, Keebler Health, a clinical documentation startup, raised $16 million in a Series A funding round to accelerate commercial growth in the U.S.